Ferroptosis signaling pathway
Schematic illustration of ferroptosis signaling pathway. Ferroptosis starts with Fe3+-bound transferrin (Tf) endocytosis via transferrin receptor 1 (TfR1). After endocytosis, Fe3+ is released from the Tf–TfR1 complex and is reduced to Fe2+ by endosomal metalloreductase, STEAP. Fe2+ can be transported and stored in ferritin by divalent metal transporter 1 (DMT1 or SLC11A2) or remain in the cytoplasm as a labile iron (Fe2+) pool (LIP). Fe2+-/Fe3+-catalyzed Fenton reaction generates the hydroxyl radical (OH•) that reacts with membrane lipids (the free polyunsaturated fatty acids or PUFA-OH) and produces lipid peroxidation product, PUFA-OOH. Lipid peroxidation can also occur via enzymes such as lipoxygenases (LOXs) such as 15-LOX-1 isoform and P450 oxidoreductase. Ferroptosis can be interdicted by iron chelators, antioxidants, and glutathione peroxidase 4 (GPX4) that converts PUFA-OOH back to PUFA-OH, using glutathione (GSH) as a substrate. GSH synthesis occurs via the entry of cystine into the cell by system Xc− [36]. Created with BioRender.com

Publication
A Concise Review on Oxidative Stress-Mediated Ferroptosis and Cuproptosis in Alzheimer’s Disease (2023) Xudong Huang, et al. Cells. 2023 May;12(10). Figure: F5.Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
---|---|---|---|---|---|---|
Homo sapiens | Primates | (Tf) | TF | ncbigene_symbol | TF | 7018 |
Homo sapiens | Primates | (TfR1) | TFR1 | ncbigene_synonym | TFRC | 7037 |
Homo sapiens | Primates | SLC1A5 | SLC1A5 | ncbigene_symbol | SLC1A5 | 6510 |
Homo sapiens | Primates | GLS | GLS | ncbigene_symbol | GLS | 2744 |
Homo sapiens | Primates | GLS | GLS | ncbigene_synonym | GLS2 | 27165 |
Homo sapiens | Primates | STEAP | STEAP | ncbigene_synonym | STEAP1 | 26872 |
Homo sapiens | Primates | GCL | GCL | ncbigene_synonym | GCLC | 2729 |
Homo sapiens | Primates | GCL | GCL | ncbigene_synonym | GCA | 25801 |
Homo sapiens | Primates | GCL | GCL | ncbigene_synonym | GMCL1 | 64395 |
Homo sapiens | Primates | GCL | GCL | ncbigene_synonym | GMCL2 | 64396 |
Homo sapiens | Primates | GSS | GSS | ncbigene_symbol | GSS | 2937 |
Homo sapiens | Primates | GSS | GSS | ncbigene_synonym | PRNP | 5621 |
Homo sapiens | Primates | DMT1 | DMT1 | ncbigene_synonym | DMRT1 | 1761 |
Homo sapiens | Primates | DMT1 | DMT1 | ncbigene_synonym | SLC11A2 | 4891 |
Homo sapiens | Primates | DMT1 | DMT1 | ncbigene_synonym | CHMP2B | 25978 |
Homo sapiens | Primates | LIP | LIP | ncbigene_synonym | SMG1 | 23049 |
Homo sapiens | Primates | GPX4 | GPX4 | ncbigene_symbol | GPX4 | 2879 |
Homo sapiens | Primates | P450 | P450 | ncbigene_synonym | CYP2B6 | 1555 |
Word | Match | MeSH | Name | ChEBI |
---|---|---|---|---|
Gln | Gln | L-glutamine residue | chebi:30011 | |
Fe3+ | Fe3+ | iron(3+) ion | chebi:29034 | |
Fe2+ | Fe2+ | iron(2+) | chebi:29033 | |
GSH | GSH | L-gamma-glutamyl-L-cysteinylglycine | chebi:16856 | |
Iron chelators | iron chelators | chebi:38157 | ||
Antioxidants | antioxidants | chebi:22586 | ||
Lipid | Lipid | lipids | chebi:18059 |
Disease mentions
Word | Match | MeSH | Name | DOID |
---|